PDL Biopharma Inc (PDLI) Dividend History
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Last update 04/25/2024
Dividend Yield Summary
|
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Dividends |
- |
0.08 |
- |
- |
- |
- |
Average Price |
3.04 |
2.98 |
- |
- |
- |
- |
Yield |
- |
2.69% |
- |
- |
- |
- |
• The above Dividend, Average Price, and Yield values for 2024 are year-to-date.
Dividend Dates
Ex Dividend Date |
2020-09-21 |
Dividend Pay Date |
|
DivInfo Metrics ™
52-Week Projected Earnings Per Share |
-1.13 |
52-Week Projected Dividends Per Share |
0.08 |
Dividend Cover |
-14.13 : 1 |
52-Week Projected Yield |
- |
52-Week Trailing Yield |
- |
6-Year Average Yield |
1.33% |
6-Year Dividend Change |
- |
6-Year Yearly Dividend Change |
- |
Number of Dividend Payments
(2008-05-05 - 2020-09-21)
|
29 |
Dividend History
Date |
Amount Per Share |
Note |
2020-09-21 |
$0.08 |
|
2016-06-02 |
$0.05 |
|
2016-03-02 |
$0.05 |
|
2015-12-02 |
$0.15 |
|
2015-09-02 |
$0.15 |
|
2015-06-03 |
$0.15 |
|
2015-03-03 |
$0.15 |
|
2014-12-03 |
$0.15 |
|
2014-09-03 |
$0.15 |
|
2014-06-03 |
$0.15 |
|
2014-03-03 |
$0.15 |
|
2013-12-03 |
$0.15 |
|
2013-09-03 |
$0.15 |
|
2013-06-03 |
$0.15 |
|
2013-03-01 |
$0.15 |
|
2012-12-05 |
$0.15 |
|
2012-09-05 |
$0.15 |
|
2012-06-05 |
$0.15 |
|
2012-03-05 |
$0.15 |
|
2011-12-06 |
$0.15 |
|
2011-09-06 |
$0.15 |
|
2011-06-06 |
$0.15 |
|
2011-03-04 |
$0.15 |
|
2010-10-01 |
$0.50 |
|
2010-04-01 |
$0.50 |
|
2009-12-15 |
$1.67 |
|
2009-10-01 |
$0.50 |
|
2009-04-01 |
$0.50 |
|
2008-05-05 |
$4.25 |
|